Theophylline for Treatment of Pseudohypoparathyroidism
Condition(s):Pseudohypoparathyroidism; Pseudohypoparathyroidism Type 1a; Albright Hereditary OsteodystrophyLast Updated:August 23, 2023Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Pseudohypoparathyroidism; Pseudohypoparathyroidism Type 1a; Albright Hereditary OsteodystrophyLast Updated:August 23, 2023Enrolling by invitation
Condition(s):Diaphragmatic Dysfunction in Critically Ill PatientsLast Updated:February 13, 2020Unknown status
Condition(s):PHP Ia; PHP IB; Php1CLast Updated:July 22, 2022Recruiting
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:March 17, 2022Completed
Condition(s):SyncopeLast Updated:January 20, 2021Completed
Condition(s):Non-small Cell Lung Cancer; Advanced Solid MalignanciesLast Updated:May 3, 2019Terminated
Condition(s):Covid19; Anosmia; Olfactory Disorder; Covid-19 Pandemic; SARS-CoV-2 Infection; Hyposmia; Ageusia; HypogeusiaLast Updated:May 24, 2023Completed
Condition(s):Pseudohypoparathyroidism; Albright Hereditary Osteodystrophy; Pseudohypoparathyroidism Type 1aLast Updated:October 5, 2022Recruiting
Condition(s):COPD; COPD Exacerbation; COPD Exacerbation Acute; Pollution Related Respiratory Disorder; Pollution; ExposureLast Updated:August 15, 2023Active, not recruiting
Condition(s):Acute Kidney Injury; HIELast Updated:June 9, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.